Case Reports Open access

First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome

Authors

Published
3 August 2017
Section
Case Reports
DOI
10.4081/reumatismo.2017.923
Pages
75-77

Abstract

Inflammatory myopathies as para-neoplastic phenomena were first described by Sterz in 1916. Recently, myositis specific autoantibodies were described in cancer-associated myositis. Anti-transcription intermediary factor 1 gamma (anti-TIF1γ) antibodies have been found in both young adults affected by juvenile dermatomyositis and in elderly patients with cancer-associated myositis. In this regard, we report herein the first case of anti-TIF1γ dermatomyositis secondary to a myelodysplastic syndrome.

Keywords

Supporting Agencies

-

Author Biographies

  • B. Palterer, Experimental and Clinical Medicine Dept., University of Florence, Florence

    Resident in Allergy and Clinical Immunology

  • G. Vitiello, Experimental and Clinical Medicine Dept., University of Florence, Florence

    Resident in Allergy and Clinical Immunology

  • D. Cammelli, Rheumatology Section/Immunoallergology Unit, AOU-Careggi, Florence

    Head of the Reumatology Section of the Immunoallergology Unit

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.

PlumX Metrics

License

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.